Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in TCRX — TScan Therapeutics, Inc.

CIK 1263508 NEW YORK, NY
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,729,096
-$83,543 QoQ
Shares Held
2,784,792
0.0% QoQ
Ownership
4.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 60 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. TCRX ranks #72 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in TCRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,729,096 2,784,792
2026-03-31 $2,812,639 2,784,792
2025-12-31 $2,784,792 2,784,792
2025-09-30 $5,068,321 2,784,792
2025-06-30 $4,037,948 2,784,792
2025-03-31 $3,843,012 2,784,792
2024-12-31 $8,465,767 2,784,792
2024-09-30 $13,868,264 2,784,792
2024-06-30 $16,291,033 2,784,792
2024-03-31 $22,111,248 2,784,792
2023-12-31 $16,235,337 2,784,792
2023-09-30 $7,129,067 2,784,792
2023-06-30 $6,961,980 2,784,792
2023-03-31 $5,848,063 2,784,792
2022-12-31 $4,316,427 2,784,792
2022-09-30 $8,493,615 2,784,792
2022-06-30 $8,758,170 2,784,792
2022-03-31 $3,990,000 1,425,000
2021-12-31 $6,412,500 1,425,000
2021-09-30 $11,884,500 1,425,000